Latest news
25 items- PRBoston Scientific Announces Results for Third Quarter 2024MARLBOROUGH, Mass., Oct. 23, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.209 billion during the third quarter of 2024, growing 19.4 percent on a reported basis, 19.5 percent on an operational1 basis and 18.2 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $469 million or $0.32 per share (EPS), compared to $505 million or $0.34 per share a year ago, and achieved adjusted3 EPS of $0.63 for the period, compared to $0.50 a year ago.
- SECSEC Form 15-12G filed by Silk Road Medical Inc.15-12G - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form EFFECT filed by Silk Road Medical Inc.EFFECT - Silk Road Medical Inc (0001397702) (Filer)
- 13D/GAmendment: SEC Form SC 13D/A filed by Silk Road Medical Inc.SC 13D/A - Silk Road Medical Inc (0001397702) (Subject)
- INSIDERDirector Zurbay Donald returned 12,610 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERDirector Weatherman Elizabeth H returned 155,004 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERDirector Lasersohn Jack W returned 16,735 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERDirector Chou Tony M. returned 85,251 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERDirector Carino Tanisha returned 11,396 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERDirector Ballinger Kevin J. returned 23,666 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERDirector Anderson Rick D returned 11,966 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDEREVPClin&Reg.Affairs&QA Ruedy Richard returned 232,031 shares to the company and was granted 26,250 shares, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERVP, Finance and CAO Jones Marie L. returned 79,266 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDEREVP/Chief Legal Officer/Sec. Klemz Kevin M returned 191,988 shares to the company and was granted 29,062 shares, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERChief Commercial Officer Davis Andrew S. returned 332,295 shares to the company and was granted 42,218 shares, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERCOO & CFO Buchanan Lucas W. returned 567,689 shares to the company and was granted 50,876 shares, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- INSIDERChief Executive Officer Mckhann Chas returned 2,021,438 shares to the company and was granted 1,299,042 shares, closing all direct ownership in the company (SEC Form 4)4 - Silk Road Medical Inc (0001397702) (Issuer)
- SECSEC Form 25-NSE filed by Silk Road Medical Inc.25-NSE - Silk Road Medical Inc (0001397702) (Subject)
- SECSEC Form S-8 POS filed by Silk Road Medical Inc.S-8 POS - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form S-8 POS filed by Silk Road Medical Inc.S-8 POS - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form S-8 POS filed by Silk Road Medical Inc.S-8 POS - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form S-8 POS filed by Silk Road Medical Inc.S-8 POS - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form S-8 POS filed by Silk Road Medical Inc.S-8 POS - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form S-8 POS filed by Silk Road Medical Inc.S-8 POS - Silk Road Medical Inc (0001397702) (Filer)
- SECSEC Form POS AM filed by Silk Road Medical Inc.POS AM - Silk Road Medical Inc (0001397702) (Filer)
SILK FAQ
7 questionsWhat does Silk Road Medical Inc. do?
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for...Where does SILK stock trade?
Silk Road Medical Inc. (SILK) is listed on NASDAQ.What sector and industry is SILK in?
Silk Road Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Silk Road Medical Inc. go public?
Silk Road Medical Inc. (SILK) completed its IPO in 2019.What are analysts saying about SILK?
Silk Road Medical Inc. has had 8 recent analyst actions on file. The most recent action was from Argus: Sell on 2024-07-11. Recent price targets range from $1200.00 to $2400.00.What companies are similar to SILK?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare SILK side-by-side with any of them on Quantisnow.How can I track SILK on Quantisnow?
Quantisnow aggregates Silk Road Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SILK to receive live email and push alerts on every new disclosure.